Although essential fatty acids (EFA) and their longer chain, more unsaturated derivatives play a major role during pregnancy, hardly any information is available with respect to the course of the maternal EFA status during an uncomplicated pregnancy and its relationship to the neonatal EFA status.
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Secher & Olsen, 1990; Baker & Broughton-Pipkin, 1991 ; Popeski et al. 1991) . Other fatty acids also seem to be important in pregnancy; decreased maternal levels of linoleic acid (1 8 : 2n-6, LA) have been observed in pregnancy-induced hypertension (Schouw et al. 1991; Wang et al. 1991) and intra-uterine growth retardation (Vilbergsson et aE. 1991) . Therefore, fatty acids like LA, AA and DHA may be of great importance in the diet of pregnant women. However, most studies that relate pregnancy complications to EFA status are based on retrospective case-control designs, using material collected in late pregnancy or postpartum. Therefore, these studies do not allow any conclusion with respect to a possible cause-and-effect relationship. Such a conclusion would require prospective longitudinal monitoring of the maternal EFA status and comparison of the maternal EFA courses during normal and complicated pregnancies. Hardly any information is presently available with respect to the course of the maternal EFA status during uncomplicated pregnancy. Therefore, we performed a longitudinal study to investigate the EFA status of women during normal pregnancy. In addition, the relationship between maternal and neonatal EFA status was investigated.
S U B J E C T S , MATERIALS A N D M E T H O D S

Study design
At their first antenatal medical visit, pregnant women were asked to participate in the study. The selection criteria for entering the study were a gestational age less than 16 weeks, singleton pregnancy, Caucasian race, diastolic blood pressure below 90 mmHg, and the absence of any metabolic, cardiovascular, neurological or renal disorder. In total, 140 women entered the study. Excluded were women who developed pregnancy-induced hypertension (n 11) or gestational diabetes (n 2), women whose babies were delivered before 37 weeks (n 8) or after 42 weeks (n 5) gestation, and women whose babies were not of an appropriate size for gestational age (< percentile 2.3 (n 3) and > percentile 97.7 (n I), based on the Dutch intrauterine growth curves, making allowance for sex and parity (Kloosterman, 1970) ). Finally, 110 women with an uncomplicated pregnancy met the inclusion criteria. Their relevant clinical information is summarized in Table 1 . Maternal venous blood samples were collected into EDTA-tubes at 10 weeks gestation (n 45), at 14 weeks (n 98), at 18 weeks (n 101), at 22 weeks (n 97), at 26 weeks (n 98), at 30 weeks (n lOS), at 32 weeks (n 103), at 34 weeks (n IOO), at 36 weeks (n lOl), at 38 weeks (n 86) and at 40 weeks (n 39). Immediately after delivery a blood sample from the umbilical vein (n 98) and a maternal venous blood sample (n 95) were also collected. At least 6 months postpartum, forty-three women gave a blood sample once more. Of these forty-three women, only four were still breastfeeding their child at the time of blood sampling. The protocol was approved by the Ethics Committee of the University of Limburg and written consent was obtained from each participant.
Biochemical analyses
Plasma was separated from erythrocytes by centrifugation and stored at -80" until fatty acid analysis. All plasma samples of a given subject were analysed simultaneously. To check whether the fatty acid profiles changed with different lengths of storage time at -8O", Pearson correlation coefficients were calculated between the relative amounts of fatty acid in maternal or umbilical plasma phospholipid and storage time at -80". Since no important significant correlations were observed, an effect of storage time on the fatty acid profile can be excluded.
Fatty acid composition analysis of the phospholipid fraction was performed using 100 ,ul plasma samples. A total lipid extract was prepared using a modified Folch extraction , and 100 mg butylated hydroxytoluene dissolved in 100 ml methanol. Aminopropyl bonded silica columns (500 mg) were used to separate phospholipids from the total lipid extract (Kaluzny et al. 1985) . The phospholipids were saponified and the fatty acids transmethylated to the corresponding fatty acid methyl esters (FAME) by reaction with BF, in methanol (140 g/l) at 100" for 1 h (Morrisson & Smith, 1964) . The FAME were separated and quantified using a HP 5890 I1 gas chromatograph (Hewlett Packard, Amstelveen, The Netherlands) fitted with a 50 m CP Sil5 CB nonpolar capillary column with 025 mm i.d. and 0.12 pm film thickness (Chrompack, Middelburg, The Netherlands) and a split ratio of 1 : 40. The injection temperature was 250" and the detector temperature 300". The starting temperature of the column was 160". After 2 min the temperature increased to 220" at a rate of 2"/min and fmally to 280" at a rate of 6"/min. The flow rate of the carrier gas (N,) was 35 ml/min. A standard FAME mixture was used to identify the FAME by means of the retention times. A control pooled plasma sample was analysed as part of every run to check the quality of the methods. The coefficient of variation of the amounts (mmol/l) measured for the main fatty acids of interest varied between 2.1 and 3.7% (de Jong et al. 1993). Quantification of FAME was based on the amount of 19:O internal standard FAME recovered. The results were expressed in absolute amounts (mg/l plasma) as well as in relative amounts (% total fatty acids).
EFA status variables
Two indices were calculated to describe the EFA status of the mother and her newborn child. The DHA deficiency index (DHADI; A1 et al. 1990; Hornstra et al. 1992) , defined as the ratio between 22:5n-6 and 22:4n-6, was used because a deficit of 22:6n-3 is at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19950106
accompanied by an increase in the conversion of 22:4n-6 to 22:5n-6, resulting in higher DHADI values (Neuringer et al. 1986 ). The other index was the EFA status (Hornstra et al. 1992) , defined as the ratio between the sum of the n-3 and n-6 fatty acids and the sum of the n-7 and n-9 fatty acids. In general, if the supply of n-3 and n-6 fatty acids is sufficient, the desaturation of oleic acid to the long-chain polyunsaturated fatty acids of the n-9 family is limited, leading to higher EFA status values. The EFA status was used instead of the classic triene: tetraene ratio (an indicator of EFA deficiency; Holman, 1960) , because this ratio does not account for changes in A-5-desaturase activity (Hornstra, 1992) .
Statistical analyses
During the gestational period (10-40 weeks), not all blood samples were taken at exactly the intended days, for practical reasons. Since we wanted to analyse values at specified gestational ages, the values of the fatty acid amounts and percentages at those days were estimated by linear interpolation between the days when blood had been sampled. For blood samples taken within 1 week before or after the intended sampling day, interpolation was considered unnecessary. Because of remaining missing values, means were estimated with adjustment for missing values using the repeated measures analysis program BMDP 5V (Jennrich & Schluchter, 1986; Dixon, 1990) . This program adjusts the means using the correlations between measurement times.
Using a model with a quadratic dependence of the fatty acid variable on time, we tested whether the temporal trend was possibly increasing or decreasing and whether there was an upward or downward curve to the trend. Data from blood samples at 10 weeks gestation, immediately postpartum (PP), 6 months after delivery (AD), and from the umbilical vein (UV) were analysed in a similar model. The values from weeks 22-32 were included in this analysis to take full advantage of the missing values adjustment. Comparisons of PP, AD, UV, and week 10 were done by the Wald test (Dixon, 1990) .
Pearson correlations were used to correlate maternal with neonatal values at delivery and to relate the variables gestational age, birthweight, head circumference and placental weight and size with maternal values early in pregnancy (weeks 10,14 and 18) and maternal and neonatal fatty acid values at delivery. Correlation coefficients were calculated for DHADI and EFA status and for the absolute and relative amounts of total saturated fatty acids (CSAFA), total monounsaturated fatty acids (EMUFA), total n-3 (Cn-3), total n-6 (Cn-6), 18 : 2n-6, 20 : 4n-6 and 22 : 6n-3. Multiple regression was performed to adjust for the potential confounding variables parity, maternal height, weight and age, smoking habits and educational level of the mother and sex of the neonate for the relationship between gestational age and fatty acid values. When studying the association between size of the newborn, placental weight and placental size and fatty acid levels, gestational age was also included as a potential confounder.
When groups were compared, Student's t test was performed.
RESULTS
Plasma fatty acids of chain lengths ranging from 14 to 24 C atoms were identified; however, only the three major EFA, namely LA (1 8 : 2n-6), AA (20 : 4n-6) and DHA (22 : 6n-3), En-6, Cn-3, CSAFA and CMUFA and the two indices DHADI and EFA status are discussed in the present paper. The full results are available on request.
The results are presented mostly in Figures, showing the mean amounts (with their standard errors) of fatty acids in maternal venous plasma phospholipids (PL) during gestation, in maternal (M) and umbilical (U) venous plasma PL immediately after delivery, and in maternal venous plasma PL at least 6 months postpartum.
The maternal fatty acid patterns during pregnancy The average total amount of fatty acid (TF) in maternal venous plasma PL increased significantly (P < 0.0001) during pregnancy (Fig. l) , but the rise in TF became less pronounced towards the end of gestation (P < 00001). The mean amount of TF increased by 51 % from 1238.1 1 mg/l at week 10 to 1867-84 mg/l at week 40 of gestation. All the fatty acid families, when expressed as mg/l plasma, showed a similar course: the En-6 increased by 44 %, the En-3 by 41 %, the ZSAFA by 57 % and the ZMUFA by 65 YO from week 10 to week 40 (results not shown). Among the individual fatty acids LA, AA and DHA (Fig. l) , the highest increment was for DHA (52 YO), followed by LA (48 YO) and AA (23 %). Six months after delivery, TF in maternal plasma PL had returned to levels comparable with those at the 14th week of pregnancy. The same applied to Zn-6, ZSAFA, EMUFA, LA and AA. The mean absolute amounts of DHA and En-3 had declined to levels significantly (P < 0.01) lower than those at 10 weeks gestation.
The relative amounts of the fatty acids did show a different pattern compared with the absolute amounts. For ZSAFA and ZMUFA in maternal plasma PL a significant (P < 0.0001) increase was observed throughout pregnancy (Fig. 2) . After a slight increase at the end of the first trimester the En-3 decreased significantly (P < 0.0001) during pregnancy and levelled off at the end of gestation. The mean relative amounts of En-6 steadily diminished (P < 0.000 1) throughout pregnancy (Fig. 2 ). This latter observation was mainly due to the maternal AA status which declined from 9.6 % at week 10 to 7.8 % at week 40 (Fig. 3) . The maternal DHA status also diminished, but only after a temporary increase until 18 weeks of gestation. In contrast, the maternal LA status did not change throughout pregnancy (Fig. 3) .
While 6 months after delivery the En-6, EMUFA (Fig. 2 ) and the relative amounts of LA and AA in maternal plasma PL (Fig. 3 ) had returned to early pregnancy levels, the ESAFA levels were comparable with those midway through gestation (Fig. 2) . After delivery the maternal DHA status decreased further to 2.8% 6 months postpartum, which was significantly (P < O*OOOl) lower than at 10 weeks gestation (Fig. 3) . A similar pattern was observed for the En-3 (Fig. 2 ) which declined to 4 5 % 6 months postpartum.
The DHADI increased significantly (P < 0.0001) throughout gestation (Fig. 4) and levelled off towards the end of pregnancy (P < O*OOOl). Six months after delivery the DHADI was equal to the DHADI at 10 weeks gestation. The EFA status declined continuously throughout the duration of pregnancy. Six months after birth the maternal EFA status had returned to early pregnancy levels.
Comparison between maternal and neonatal fatty acid values
The mean amount of TF in umbilical plasma PL was substantially lower (P c 0.0001) than all maternal values (Fig. 1) . This was observed for all four fatty acid families: for ZSAFA and EMUFA the mean amount (mg/l) in umbilical plasma PL was only about 35 % that in maternal plasma PL at delivery; for En-6 and En-3 these proportions were 32 and 47 YO respectively (results not shown). The mean amount of LA (mg/l) in umbilical plasma PL (Fig. 1) was only 13% of the maternal value at delivery, while for AA and DHA the percentages were 68 and 56% respectively (P < 0.0001 for all three fatty acids). The neonatal value for DHA was not significantly different from the maternal level 6 months after delivery (Fig. 1) .
In contrast to the absolute amounts of AA and DHA, the mean relative amounts of AA and DHA in umbilical plasma PL were significantly (P < 0.0001) higher than all maternal values (Fig. 3) . However, the mean relative amount of LA in umbilical venous plasma PL was significantly (P < 0.0001) lower than that of the mother (Fig. 3) . This resulted in a Results are for 110 subjects after correction for missing values; the number of subjects in the original data set is given above each histogram bar. SAFA, saturated fatty acids; MUFA, monounsaturated fatty acids; n-3, fatty acids of the n-3 family; n-6, fatty acids of the n-6 family. significantly lower En-6 in umbilical plasma PL compared with maternal plasma PL, despite the higher neonatal AA levels (Fig. 2) . The amounts of Zn-3 and ZSAFA in umbilical plasma PL were significantly (P < 0.0001) higher than the maternal values. For XMUFA no significant difference between mother and child was observed.
The mean DHADI value in umbilical venous plasma PL was significantly (P < 0.0001) lower than the maternal DHADI immediately after delivery, but significantly (P < 0.0001) higher than the maternal DHADI 6 months postpartum and at 10 weeks gestation (Fig. 4) .
The neonatal EFA status did not differ significantly from the maternal value at delivery, but was significantly (P < 0.005) lower than the EFA status in maternal plasma PL 6 months after birth and during early pregnancy (Fig. 4) . 
TF, sum of total fatty acids; ZSAFA, sum of saturated fatty acids; EMUFA, sum of monounsaturated fatty acids; Zn-6, sum of fatty acids of the n-6 family; Zn-3, sum of fatty acids of the n-3 family.
In Table 2 Pearson correlation coefficients between postpartum maternal and umbilical venous plasma values are shown for TF, and for the relative amounts of ZSAFA, ZMUFA, En-6, En-3, LA, AA and DHA. No significant correlation was observed for TF, but all the other fatty acids and fatty acid combinations did show a highly significant positive correlation.
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Relationship of maternal and neonatal fatty acid composition in plasma PL with some clinical variables and smoking habits of the mother Because of the large number of comparisons made, only those with P < 0.01 are reported
For maternal values, a significant positive correlation was only observed between the amount of AA (% TF) in maternal plasma PL at 10 weeks gestation and birth weight (r +039, P = 0.007, n 45). This correlation did not hold for the other time points.
The amount of LA (YO TF) in umbilical plasma PL was negatively correlated with gestational age (r -0.37, P = 0.0001, n 98). The relative, as well as the absolute, amounts of DHA and En-3 in umbilical plasma PL correlated positively with gestational age (YO TF : r + 0.38, P = 0.0001 for DHA and En-3; mg/l: r + 0.42, P < 0.0001 for DHA and r + 0.43, P < 0.0001 for En-3). Significant positive correlations were also observed between placental weight and the absolute amounts in umbilical plasma PL for AA (r +0*27, P = 0-007), DHA (r +0.29, P = 0.005), En-3 (r +0.29, P = 0.005) and XSAFA (r +0*28, P = 0.006, n 96). These associations did not change when correcting for the potential confounders parity, maternal height, weight and age, smoking habits and educational level of the mother, sex of the neonate and gestational age. After adjustment for parity, a significant negative correlation was found between the relative amount of LA in umbilical plasma PL and head circumference (partial r -036, P = 0001). Introducing gestational age in the multiple regression analysis did not alter the above conclusion.
No differences were observed between smokers (n 32) and non-smokers (n 78) for the various fatty acids and fatty acid families in maternal and neonatal plasma PL at delivery. The mean absolute amounts of DHA and En-3 in umbilical plasma PL were significantly higher in girls than in boys (DHA: 40 (SE 2.0) v. 33 (SE 1*1), P = 0-009; En-3: 46 (SE 2.3) v. 38 (SE 1.5), P = O*OOS). No significant differences in gestational age were observed between boys and girls.
DISCUSSION
To our knowledge, this is the first report about the EFA composition of maternal plasma PL measured longitudinally throughout normal pregnancy, in an absolute (mg/l) and in a relative (% TF) manner. The decision to use the PL fraction was based on the fact that PL are structural lipids, which are the richest source of polyunsaturated fatty acids (PUFA). Moreover, changes in PUFA profile are most pronounced in PL (Holman, 1986 ) reflecting the EFA status best.
To correct for the unavoidable missing values, an analysis model was chosen which estimated the means with adjustment for the missing data. The uncorrected data, however, showed a similar course to that of the corrected data. Moreover, the correction factor was never more than 2.5 YO.
The increases in absolute amounts of fatty acids in maternal plasma PL throughout normal pregnancy (Fig. 1) were a direct consequence of the enhanced PL concentration during gestation (Desoye et al. 1987) . The increase in TF during pregnancy could not be calculated, because prepregnancy levels were not available. As an approximation, maternal blood samples, taken 6 months after delivery, were analysed. In these samples the amounts of most of the fatty acids were comparable with their values at the end of the first trimester. Eighteen women provided information at 8 weeks gestation and the fatty acid levels in the plasma PL of these samples were lower than at 10 weeks. This strongly indicates that the absolute maternal fatty acid levels measured 6 months after delivery do not yet reflect true prepregnancy levels which are still appreciably lower.
During pregnancy the increment observed for DHA in maternal plasma PL was the highest for all PUFA, and compared with prepregnancy levels (which are most probably lower than the levels 6 months after delivery, see above) the absolute amounts doubled during gestation. This probably reflects the special requirement for DHA by the developing brain and retina (Clandinin et uf. 1980; Martinez, 1989; Uauy et al. 1992; Makrides et af. 1993) .
In theory, the improved absolute maternal DHA status could result from a change in dietary habits, an increase in fish consumption in particular. However, a dietary study in which 176 Dutch pregnant women had to fill out a food-frequency questionnaire before 13, at 22 and at 32 weeks of pregnancy showed no significant changes in the amount and type of fat consumed by these women throughout gestation (Al, 1994) . Another explanation could be an increase in the activity of the enzymes involved in the synthesis of DHA from its precursors. However, this process occurs at a very low rate only (Voss et al. 1992) and, therefore, it seems more likely that the improved maternal DHA status during pregnancy is caused by an increased mobilization from maternal stores, although a metabolic rerouting (from energy substrate to structural use) cannot be excluded.
When expressed in relative terms, the maternal DHA increase lasted until 18 weeks gestation. Thereafter a gradual decrease was seen, which may reflect the maternal inability to mobilize adequate amounts for optimal fetal development. These changes in the maternal DHA status during pregnancy may be normal physiological phenomena. However, the continuous increase of the DHADI may point to a progressive deterioration of the maternal DHA status, suggesting that under the prevailing dietary conditions the maternal capacity to meet the high fetal requirement for DHA (Innis, 1991 ) is working at its limits or may even be inadequate. The significantly higher DHADI values in umbilical plasma compared with the maternal non-pregnant values also indicate that the mother is unable to provide an optimum fetal DHA status. Whether or not the fetus will benefit from a higher maternal DHA status can only be established by controlled dietary intervention studies.
The AA status (% TF) in umbilical venous plasma PL was, like DHA, significantly higher than the maternal relative amount, despite the decrease of the maternal AA status throughout pregnancy. This might point to a high neonatal need for AA which is the most abundant fatty acid of the n-6 family in neural tissue and the retina (Svennerholm, 1968; Fliesler & Anderson, 1983; Sastry, 1985) .
No changes were observed for the maternal LA status throughout pregnancy. The neonatal relative amounts of LA were almost three times lower than the maternal plasma values. Results from a recent study demonstrated that the low fetal amounts of LA originate early in pregnancy (van Houwelingen et al. 1992) . In spite of the low LA levels in umbilical venous plasma PL, the neonatal EFA status did not differ from the maternal EFA status at delivery. However, since the neonatal EFA status was significantly lower than the maternal EFA status 6 months postpartum and at 10 weeks gestation, the question arises whether the neonatal EFA status is indeed optimal.
The absolute amounts of the fatty acids in umbilical plasma were significantly lower compared with maternal values, because the total phospholipid concentration was significantly lower in cord blood than in maternal blood at delivery (see Fig. 1 ). The significantly higher relative amounts of AA and DHA could be due to de now synthesis by the fetus, but since the capacity of the placenta and fetal liver to synthesize the long-chain PUFA (LCP) AA and DHA from their parent EFA LA and a-linolenic acid (18:3n-3, a-LA) is very limited (Chambaz et af. 1985) , other mechanisms must be responsible for the different fatty acid profiles for LA, AA and DHA between maternal and umbilical plasma PL. These could be caused by preferential transport of LCP across the placenta, but selective sequestering of AA and DHA, at the expense of LA, into PL on the fetal side of the placenta (Kuhn & Crawford, 1986 ) may also be responsible. As a consequence, AA and at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19950106 DHA are compartmentalized into a lipid fraction that does not recross the placental barrier (Coleman, 1989) and therefore remains available for the developing tissues, like brain and retina. A possible important role in the transport of LCP in the fetal circulation may be reserved for a-fetoprotein (AFP). This protein is mainly synthesized by the fetal liver and the yolk sac. Although the biological role of AFP is not completely elucidated, it binds PUFA, mainly AA and DHA, with high affinity. Because these fatty acids are important components of structural lipids, the transport and cell delivery of LCP could be a major physiological activity of AFP (Subbiah, 1991) .
The placenta is, for the greater part, a fetal organ which has a fatty acid composition more similar to that of fetal plasma than of maternal plasma (Chambaz et al. 1985; A1 et al. 1990 ). This might explain why significant correlations were observed for placental weight with some fetal fatty acid values, but not with maternal fatty acid levels.
A significant positive correlation between DHA and En-3 in umbilical plasma PL and gestational age was observed. In a preterm population (n 22) Leaf et al. (1992) also observed a significant positive correlation between 22 : 6n-3 in neonatal plasma cholinephosphoglyceride and gestational age. Negative correlations were demonstrated in the present study for LA (% TF) with gestational age and with head circumference. These associations were not reported by Leaf et al. (1992) , although they found positive correlations for birth weight and head circumference with the sum of 20 : 3n-6 + 20 : 4n-6 and with 22:6n-3. These latter two associations, however, were not observed in our term population, where all infants were born between 37 and 42 weeks gestation, while in the preterm population the range in gestational age was 12 weeks. This wider range in gestational age could partly explain the difference in result. Moreover, it is known that head circumference of the newborn, for instance, also depends on such factors as the head circumferences of the parents, duration of expulsion, the way of delivery and method of recording head circumference. Corrections for these possible confounders were not made.
At the moment, the modification of the fatty acid composition of infant milk formulas to ensure an optimal administration of AA and DHA after birth is under discussion. On the basis of the results described in the present paper it can be concluded that lipid nutrition of high quality during gestation is also important, especially with respect to DHA. The correlations between the maternal and umbilical relative amounts for LA, AA and DHA are strong and suggest that the fetal EFA status can be influenced by the mother.
This study has yielded data both on the course of the maternal EFA profiles throughout normal pregnancy and on the EFA status of umbilical venous plasma and maternal plasma, 6 months after delivery. In addition, the fatty acid composition was determined as mg/l and as %TF. These results will serve as reference values in a further comparison between uncomplicated and complicated pregnancies which is presently being executed.
